Forbes - The company is simultaneously conducting several clinical and preclinical trials with the two drugs for various indications. CF101 is being studied for the treatment of rheumatoid arthritis, dry eye syndrome and psoriasis. Can-Fite has also entered Read More
Tuesday, November 20, 2007
Can-Fite: CF101 May Be Effective for the Treatment of Crohn's Disease
Subscribe to:
Post Comments (Atom)


0 comments:
Post a Comment